- Home
- MRNA vs ASR Comparison
MRNA vs ASR Comparison
Compare MRNA & ASR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | ASR |
|---|---|---|
| Founded | 2010 | 1996 |
| Country | United States | Mexico |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Aerospace |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 9.7B |
| IPO Year | 2018 | 2000 |
Fundamental Metrics
Financial Performance| Metric | MRNA | ASR |
|---|---|---|
| Price | $51.78 | $336.17 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 5 |
| Target Price | $32.75 | ★ $337.50 |
| AVG Volume (30 Days) | ★ 11.8M | 32.2K |
| Earning Date | 02-13-2026 | 02-23-2026 |
| Dividend Yield | N/A | ★ 11.30% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.03 |
| Revenue | ★ $2,232,000,000.00 | $1,923,920,463.00 |
| Revenue This Year | N/A | $13.32 |
| Revenue Next Year | $3.18 | $10.82 |
| P/E Ratio | ★ N/A | $16.50 |
| Revenue Growth | N/A | ★ 20.90 |
| 52 Week Low | $22.28 | $249.21 |
| 52 Week High | $50.00 | $360.00 |
Technical Indicators
Market Signals| Indicator | MRNA | ASR |
|---|---|---|
| Relative Strength Index (RSI) | 82.55 | 65.11 |
| Support Level | $39.21 | $315.94 |
| Resistance Level | $41.98 | $332.67 |
| Average True Range (ATR) | 2.93 | 8.18 |
| MACD | 1.57 | 0.38 |
| Stochastic Oscillator | 87.75 | 78.16 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About ASR Grupo Aeroportuario del Sureste S.A. de C.V.
Grupo Aeroportuario del Sureste SAB de CV and its subsidiaries hold concessions to operate, maintain, and develop airports in the southeast region of Mexico. As an operator of airports, it charges airlines, passengers, and other users fees for using the airports' facilities. The group also derives rental and other income from commercial activities conducted at its airports, such as the leasing of space to restaurants and retailers. The group's operating segments are Cancun, which generates maximum revenue, Aerostar, Airplan, Merida, Villahermosa, Holding and Services, and Others.